300+ investors in your industry, stage, and region Get
Any industry
Community
Proptech
Biotech
Climate
Artificial Intelligence
Media (Entertainment)
Impact
FinTech
Marketplace
EdTech
Consumer
Agriculture (AgTech)
Web3
Clean Energy
B2B
Organic Food
Big Data
Video Games
Payments
Celebrity
Franchise
Mobile
Local
Social Network
Platforms
Crowdfunding
CleanTech
Film
Theatre
Life Science
Non Profit
Transportation
Gaming
Energy
Hardware
Health Care
Enterprise
Sustainability
Venture Capital
Restaurants
Fashion
Real Estate
Retail
Infrastructure
Mobile Apps
Beauty
LGBT
Publishing
Sporting Goods
Oil and Gas
Education
Renewable Energy
Food and Beverage
Cryptocurrency
Finance
Financial Services
Photography
Art
Medical
Digital Media
Music
Internet
Social Media
Manufacturing
Facebook
Blockchain
Legal
Android
Social Impact
Google
Construction
Sports
eSports
Enterprise Software
Email
Wellness
Hospitality
Travel
Fitness
Mobile Advertising
Cannabis
Recruiting
Biotechnology
Medical Device
Wine and Spirits
Automotive
Social
InsurTech
SaaS
Software
Any country
Qatar
South Korea
Africa
Asia
LATAM
Europe
Oceania
Middle East
Ireland
Singapore
Indonesia
Spain
Saudi Arabia
Belarus
Belgium
Colombia
Denmark
Ecuador
Czech Republic
Estonia
Ghana
Ethiopia
Finland
Barbados
Italy
Jersey
Cayman Islands
Mali
Malaysia
Mauritius
Poland
Rwanda
Togo
Slovenia
San Marino
Tanzania
Thailand
Uruguay
Venezuela
Portugal
Azerbaijan
Namibia
Bolivia
Latvia
Cyprus
New Zealand
United States
Germany
Australia
India
United Kingdom
Canada
China
South Africa
Brazil
Japan
Sri Lanka
Vietnam
Argentina
Armenia
Austria
Bangladesh
Bahrain
Bulgaria
Bermuda
Chile
Cameroon
Switzerland
Belize
Costa Rica
Algeria
Georgia
Egypt
Hong Kong
Gibraltar
Faroe Islands
Greece
Croatia
France
Hungary
Kuwait
Israel
Lebanon
Cambodia
Kenya
Jordan
Lithuania
Liberia
Liechtenstein
Myanmar
Kazakhstan
Morocco
Norway
Mexico
Panama
Malta
Peru
Philippines
Nicaragua
Pakistan
Russian Federation
Romania
Sweden
Serbia
Seychelles
Turkey
Puerto Rico
Sierra Leone
Senegal
Tunisia
Tajikistan
El Salvador
Uganda
Zambia
Uzbekistan
Taiwan
Ukraine
Zimbabwe
Bahamas
Guatemala
Iraq
Iceland
Nigeria
United Arab Emirates
Honduras
Isle of Man
Luxembourg
Oman
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 50 Medical Device Startup Investors (May 2026)

The most active venture capital funds and angel investors investing in Medical Device startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Medical Device startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
Innova Memphis
VC Fund
71 United States, Argentina, United Kingdom Seed, Pre-Seed, Convertible Note Health Care, Medical, Medical Device $50k–$1.5M
Enterprise Ireland
VC Fund
34 Ireland, United States, United Kingdom Seed, Series A Software, Health Care, Information Technology $429k–$12M
Broadview Ventures
VC Fund
25 United States, Israel, Denmark Series A, Seed, Debt Financing Health Care, Biotechnology, Medical Device $750k–$11M
Zürcher Kantonal Bank
VC Fund
22 Switzerland, Japan, Germany Seed, Series A Health Care, Medical Device, Biotechnology $1M–$11M
Connecticut Innovations
VC Fund
18 United States, Israel, Canada Series A, Seed Health Care, Biotechnology, Software $150k–$25M
Portfolia
VC Fund
18 United States, Canada, Argentina Seed, Series A, Series B Health Care, Biotechnology, Software $48k–$15M
Boston Harbor Angels
VC Fund
17 United States, Canada, India Angel, Seed, Series A Biotechnology, Health Care, Medical Device $100k–$7.3M
CincyTech
VC Fund
17 United States Seed, Series A, Series B Software, Health Care, Biotechnology $250k–$50M
High-Tech Grunderfonds
VC Fund
17 Germany, Switzerland, United States Seed, Series A Software, Information Technology, Biotechnology $665k–$16M
HealthTech Capital
VC Fund
17 United States Seed, Series A, Convertible Note Health Care, Medical Device, Medical $1M–$11M
MB Venture Partners
VC Fund
17 United States, Israel Seed, Series B, Series C Health Care, Medical, Medical Device $50k–$28M
EIT Health
VC Fund
16 United Kingdom, Spain, Ireland Grant, Pre-Seed, Seed Health Care, Medical Device, Medical $21k–$1.4M
Oxford Finance LLC
VC Fund
16 United States, Canada, United Kingdom Debt Financing, Post-IPO Debt, Series B Biotechnology, Health Care, Medical $5M–$100M
Khosla Ventures
VC Fund
16 United States, India, United Kingdom Series A, Series B, Seed Software, Health Care, Biotechnology $1.5M–$60M
North Coast Ventures
VC Fund
16 United States Series A, Seed Health Care, Software, Medical Device $250k–$20M
Parkwalk Advisors
VC Fund
16 United Kingdom, United States, Philippines Seed, Series A, Series B Biotechnology, Health Care, Software $860k–$33M
Sofinnova Partners
VC Fund
15 France, United States, United Kingdom Series A, Series B, Series C Biotechnology, Health Care, Medical $4.4M–$57M
Wavemaker 360
VC Fund
15 United States, United Kingdom, Canada Seed, Series A Health Care, Medical, Medical Device $100k–$24M
Texas HALO Fund
VC Fund
15 United States, Canada, Hungary Seed, Convertible Note, Series A Health Care, Medical Device, Software $105k–$10M
Maine Angels
VC Fund
14 United States Seed, Series A Health Care, Software, Biotechnology $25k–$5.9M
Good Growth Capital
VC Fund
14 United States, France, Israel Seed, Convertible Note, Series A Health Care, Information Technology, Software $25k–$24M
Mercia Fund Managers
VC Fund
14 United Kingdom, United States, Hungary Seed, Series A Software, Health Care, Biotechnology $184k–$21M
Bpifrance
VC Fund
14 France, United States, Switzerland Seed, Series A Software, Health Care, Information Technology $643k–$29M
VI Partners
VC Fund
14 Switzerland, Germany, United States Series A, Series C, Series B Health Care, Biotechnology, Medical Device $3.2M–$100M
Horizon Technology Finance
VC Fund
14 United States, Canada, India Debt Financing, Post-IPO Debt Health Care, Biotechnology, Medical Device $5M–$40M
Versant Ventures
VC Fund
14 United States, Switzerland, Canada Series A, Series B, Series C Biotechnology, Health Care, Medical $3.9M–$85M
Arboretum Ventures
VC Fund
14 United States, Canada Series B, Series A, Series C Health Care, Biotechnology, Medical $3M–$90M
U.S. Venture Partners
VC Fund
13 United States, Israel, Canada Series B, Series C, Series A Software, Health Care, Information Technology $5M–$65M
Kurma Partners
VC Fund
13 France, Spain, Switzerland Series A, Seed, Series B Health Care, Biotechnology, Medical $2.1M–$80M
Ben Franklin Technology Partners of Southeastern Pennsylvania
VC Fund
13 United States Seed, Grant, Debt Financing Health Care, Software, Information Technology $5k–$1.6M
Foundation for Technological Innovation (FIT)
VC Fund
13 Switzerland, France Debt Financing, Grant, Seed Health Care, Biotechnology, Information Technology $22k–$555k
TEDCO
VC Fund
13 United States Seed, Pre-Seed, Series A Software, Health Care, Biotechnology $25k–$5M
Sand Hill Angels
VC Fund
13 United States, Canada, Japan Seed, Series B, Series A Health Care, Software, Biotechnology $1M–$35M
Silicon Valley Bank
VC Fund
13 United States, United Kingdom, Canada Debt Financing, Series B, Series A Software, Health Care, Biotechnology $4M–$145M
Wisconsin Investment Partners
VC Fund
13 United States, Canada, United Kingdom Seed, Series A Health Care, Biotechnology, Medical $134k–$17M
Oxford Bioscience Partners
VC Fund
13 United States, Germany, Switzerland Series B, Series C, Series A Health Care, Biotechnology, Pharmaceutical $3.5M–$50M
Seventure Partners
VC Fund
12 France, United States, Germany Series A, Series B Biotechnology, Health Care, Software $2.4M–$35M
Scottish Investment Bank
VC Fund
12 United Kingdom, United States, France Seed, Series A Software, Biotechnology, Information Technology $307k–$7.6M
Catalyst Health Ventures
VC Fund
12 United States Series A, Series B, Series C Health Care, Medical Device, Medical $1M–$26M
Mayo Clinic
VC Fund
12 United States, Israel, China Series A, Series B, Seed Health Care, Biotechnology, Medical $100k–$48M
Newable Private Investing
VC Fund
12 United Kingdom, United States Seed, Series A Software, Health Care, Biotechnology $184k–$3.8M
New Enterprise Associates
VC Fund
12 United States, India, China Series B, Series A, Series C Software, Health Care, Biotechnology $5M–$85M
Verve Ventures
VC Fund
12 Switzerland, Germany, France Series A, Seed, Series B Health Care, Software, Biotechnology $911k–$18M
Split Rock Partners
VC Fund
12 United States, France Series B, Series A, Series C Health Care, Medical Device, Medical $3M–$47M
Western Development Commission
VC Fund
12 Ireland, United States Seed, Series A Medical Device, Health Care, Medical $696k–$8M
Innovate Calgary
VC Fund
12 Canada, United States Seed, Pre-Seed Health Care, Medical, Medical Device $872k–$1.9M
Green Park & Golf Ventures
VC Fund
12 United States, Israel, Sweden Series A, Seed, Series B Health Care, Medical, Biotechnology $300k–$13M
Life Science Angels
VC Fund
12 United States, Israel, The Netherlands Seed, Series A Biotechnology, Health Care, Medical $605k–$20M
Pontifax
VC Fund
12 United States, Israel, France Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $3.8M–$100M
Hatteras Venture Partners
VC Fund
12 United States, Canada Series A, Series B Biotechnology, Health Care, Medical $2.6M–$90M
Access all 6731 investors in Medical Device startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

Innova Memphis
VC Fund · Memphis, Tennessee, United States · 71 investments in Medical Device startups

Founded in 2007 by the Memphis Bioworks Foundation, Innova is a pre-seed, seed and early-stage investor focused on starting and funding high-growth companies in the Biosciences, Technology and AgBio fields across the state of Tennessee. Innova links capital with great ideas to create groundbreaking products and services.At Innova we invest instart-up companies, help them grow, and then assist them in linking with established corporations for licensing, buy-outs or further investments. We provide the synergy of experienced management, market expertise and venture capital to accelerate the development of new products and services into viable business units that can stand on their own and then take their place with a mature market leader, if desired.Whether an innovation is still on the drawing board or stalled in the market place the Innova staff has the expertise, skills, and experience to envision and create a functioning business unit that is prepared to thrive in the market place. Technical know-how, market-proven staffing, and "just-right" funding assure the greatest chance possible for success.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Pre-Seed, Convertible Note
  • Geography: United States, Argentina, United Kingdom

Investor stats

  • Total investments: 240
  • Round size: Seed $50k–$1.5M; Pre-Seed $50k–$1.3M; Convertible Note $250k–$1.4M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — raised $31M in 2017

Portfolio highlights

  • Isomark Health — Isomark Health is a patented AI-based, real-time and 100% green breath technology that detects and prevents bacterial and viral infections.
  • Rantizo — Rantizo provides drone spraying systems and support services for custom applicators, agribusinesses and contractors. Elevating precision ag.
  • Glanris — Glanris developed a completely green, non-toxic, filtration media for water purification from an agriculture by-product. This agricultural product is grown around the world, is plentiful, and can be used locally to ensure clean drinking water in developing countries. It also gives local farmers a significant additional income source for a productthat today they are throwing away.This media has been independently tested over the last two years of development and is ready for production.
Show all investments...

Enterprise Ireland
VC Fund · Dublin, Dublin, Ireland · 34 investments in Medical Device startups, 19 in the past 12 months

Enterprise Ireland is the government agency responsible for the development and funding of the indigenous business sector. Their mission is to accelerate the development of companies to achieve strong positions in global markets resulting in increased national and regional prosperity. It was founded in 1998 and headquartered in Dublin, Ireland.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Series A
  • Geography: Ireland, United States, United Kingdom

Investor stats

  • Total investments: 383
  • Round size: Seed $429k–$2.9M; Series A $2M–$12M
  • Lead/follow: 15% lead, 85% follow
  • Last fund: May invest from a new fund soon — raised $1.1M in 2021

Portfolio highlights

  • CergenX — CergenX produces cutting-edge technology for the analysis of baby brain waves that can be used to identify brain injuries early in the newborn period.
  • Tailr — Redefining production for the clothing industry.
  • Recruitroo — Recruitroo is a international recruitment agency that uses technologies to streamline and improve the international recruitment process for both companies and candidates.
Show all investments...

Broadview Ventures
VC Fund · Boston, Massachusetts, United States · 25 investments in Medical Device startups

Broadview Ventures, Inc. (Broadview) was established in 2008 as a new program conceived by the Leducq family. Through Broadview, the trust will work to accelerate the development of promising technology in cardiovascular and neurovascular disease through targeted investment in and support of early stage technology ventures.The FoundationLeducq, based in Paris, France, is the beneficiary of a charitable trust. In order to further the Foundation Leducq's mission in cardiovascular and neurovascular disease, the trust has made funds available to Broadview to develop a program which will promote early state technology in these fields through investments, licensing agreements and consortium funding arrangements, as well as professional, management and consulting support.With this initiative the trust joins other leaders in the venture philanthropy movement in seeking creative solutions to the problem of what is commonly referred to as the 'translational gap', a significant component of which is a lack of funding at a critical moment in the development of new technology and science.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Seed, Debt Financing
  • Geography: United States, Israel, Denmark

Investor stats

  • Total investments: 66
  • Round size: Seed $750k–$5.4M; Series A $1M–$11M; Debt Financing $1M–$2.4M
  • Lead/follow: 24% lead, 76% follow

Portfolio highlights

  • Nyra Medical — MitraPlug has created a catheter-plug technology for repairing a leaky mitral valve in the heart.This adjustable device needs only a two-inch surgical incision and can be inserted directly into the heart. Then the cardiologist can use the catheter to adjust the size and position of the plug to correct the leakage. When correctly fitted, thecatheter is removed, and the incision is closed, leaving only a small scar.
  • RapidPulse — RapidPulse, Inc. is a privately held medical device company that develops minimally invasive vascular products for ischemic stroke. The company is advancing the development of the RapidPulse™ Cyclic Aspiration System, which includes a novel aspiration pump to allow rapid and consistent removal of blood clots from the brain. RapidPulse is a spinoutof Syntheon LLC., a medical device incubator dedicated to developing innovative products in the medical device industry
  • Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
Show all investments...

Zürcher Kantonal Bank
VC Fund · Zürich, Zurich, Switzerland · 22 investments in Medical Device startups, 17 in the past 12 months

Zürcher Kantonalbank - as an independent, incorporated public-law institution - is wholly owned by the canton of Zurich.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Biotechnology
  • Stage:Seed, Series A
  • Geography: Switzerland, Japan, Germany

Investor stats

  • Total investments: 136
  • Round size: Seed $1M–$3.9M; Series A $2M–$11M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Helio — Carbon Aware Cloud Computing.
  • Tune Insight — Tune Insight orchestrates secure collaborations on sensitive data between multiple organizations to extract collective insights.
  • Nagi Bioscience — Enabling small organisms testing to any lab. Unleash unique datapoints efficiently at a high-throughput rate.
Show all investments...

Connecticut Innovations
VC Fund · Rocky Hill, Connecticut, United States · 18 investments in Medical Device startups, 9 in the past 12 months

At Connecticut Innovations, we see venture capital the way you see your business. Like no one else. We invest in innovative biotech, IT, and other industries.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Series A, Seed
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 211
  • Round size: Seed $150k–$2.3M; Series A $1.8M–$25M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • OOVA — OOVA is a fertility diagnostic company that spun out from Mount Sinai Hospital in New York City. Using patent pending biochemistry and artificial intelligence, OOVA learns a woman’s fertility profile by accurately measuring key hormones over time through daily urine samples. By monitoring this critical balance of hormones, OOVA can help a woman getpregnant, identify reasons she is having trouble getting pregnant, and even expose reproductive health issues like PCOS.
  • Raise Green — Raise Green is the climate tech marketplace for local impact investing licensed with the SEC and FINRA to sell private securities.
  • Driver Technologies — Turn your phone into a dash cam.
Show all investments...

Portfolia
VC Fund · San Mateo, California, United States · 18 investments in Medical Device startups, 17 in the past 12 months

Investing Funds Designed for Women Backing Innovative Companies We Want in the World - For Returns and Impact

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Software
  • Stage:Seed, Series A, Series B
  • Geography: United States, Canada, Argentina

Investor stats

  • Total investments: 154
  • Round size: Seed $2M–$3.7M; Series A $48k–$15M
  • Lead/follow: 1% lead, 99% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Attn: Grace — Attn: Grace is a sustainable wellness brand designed for women. Starting with bladder leakage, they're creating thoughtful, more sustainable solutions for life’s inconvenient truths, one challenge at a time.
  • Prime Roots — Prime Roots is on a mission to provide a better cut of meat for every type of eater. Rooted in koji, Prime Roots is able to replicate the taste and texture of meat without any of the environmental costs of animal proteins.
  • Carbice Corporation — Carbice is the first no-compromise thermal interface material. It achieves all the advantages of both solid and liquid thermal interface materials without any of the pitfalls.
Show all investments...

Boston Harbor Angels
VC Fund · Boston, Massachusetts, United States · 17 investments in Medical Device startups

Boston Harbor Angels is a group of proven business leaders interested in investing a portion of their assets in high growth, early stage companies. The group was formed in February 2004 and since then has made a number of investments in companies in medical devices, IT, consumer products, business products, specialty materials, Internet, aviation,etc. They believe they contribute more than money to the companies they fund and welcome the opportunity to work with entrepreneurs open to take advice, yet having the smarts and determination to make the company successful.Their focus is on early stage companies usually looking to raise $250K to $1.5M, where they can fund a portion of the round and syndicate the deal with other angel groups or early stage venture funds. The stage of the company should be close to commercialization, while the company should have a clear and defensible competitive advantage. They are looking for capital efficient businesses, which can reach profitability with less than $5M of equity investment and provide at least 10X return on the investment within 5 years.They do not invest as a fund - each of their members makes his or her individual investment decision but they collaborate in Due Diligence. They have a deep expertise in the life sciences field where they usually take the position of a lead investor, but are open to any opportunities that can make a strong business case. In some cases they prefer to be the follow on investor if they cannot identify a person with strong expertise within their group.The group’s strategy is directed by an executive committee which consists of 8 people elected by the group: Wayne Griffith (chairman), Bill McPhee, Henry Kay, Jay Schwartz (membership director), Steve Andress, Peter Miller, Don Freeman and Mic Williams (president and founder). The group’s day-to-day operations are managed by Boris Batchvarov (managing director).They receive 20-30 business summaries each month, out of which they select 8 companies to make a personal presentation to their screening committee. The screening committee consists of volunteers from the group. The presentations are 10 min long followed by 10 min Q&A. 4 of the companies are invited to present to the whole group, with the idea to get the people interested and decide to perform a Due Diligence with the companies before making an investment.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical Device
  • Stage:Angel, Seed, Series A
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 104
  • Round size: Seed $100k–$2.4M; Angel $500k–$1.6M; Series A $662k–$7.3M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • Zylö Therapeutics — Patented technology that enables, for topicals, sustained release, increased druggability, a Patchless Patch concept, and enhanced targeting of pores and follicles
  • Xeno Biosciences — Xeno Biosciences operates as a biopharmaceutical company pioneering a novel class of therapeutics to address large unmet needs in metabolic diseases. Lead program, XEN-101, is a first-in-class, oral formulation designed to shift the gut microbiome to the weight-loss associated state induced by Roux-en-Y Gastric Bypass (RYGB) surgery.It wasfounded in 2015 and is headquartered in Somerville, Massachusetts.
  • Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Show all investments...

CincyTech
VC Fund · Cincinnati, Ohio, United States · 17 investments in Medical Device startups

CincyTech helps to identify and transform innovation into venture-worthy, transformational human health and technology companies, primarily in southwest Ohio. Our team provides advice and capital to entrepreneurs, helps research institutions commercialize technology through startups, and catalyzes investment from individuals and institutions intoregional companies. One of the most active seed funds in the Midwest, CincyTech is supported by Ohio Third Frontier, more than two dozen foundations, corporations, municipalities and individuals as well as founding partners, Cincinnati Children’s Hospital Medical Center, the University of Cincinnati, and the Cincinnati USA Regional Chamber.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A, Series B
  • Geography: United States

Investor stats

  • Total investments: 115
  • Round size: Seed $250k–$2.8M; Series A $300k–$7.5M; Series B $890k–$50M
  • Lead/follow: 55% lead, 45% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Amify — We help brands selling on Amazon maximize sales and profitability by providing complete strategy, management and operational services.
  • Tembo — CoreDB provides a fully-managed, secure, scalable Postgres cluster with access to an ecosystem of extensions, expanding the capabilities of your database.
  • Voxel — Voxel utilizes advanced mathematics and artificial intelligence to rapidly generate functionally graded meta-materials for high performance applications through additive manufacturing. We provides performance leaps in the defence, automotive, aerospace, medical, industrial, and other demanding areas and unlock new capabilities for our customers.
Show all investments...

High-Tech Grunderfonds
VC Fund · Bonn, Nordrhein-Westfalen, Germany · 17 investments in Medical Device startups, 64 in the past 12 months

High-Tech Gründerfonds (HTGF) is a seed investor that finances high-potential, tech-driven startups. With EUR 895.5 million in total investment volume across three funds and an international network of partners, HTGF has already helped forge more than 500 startups since 2005. Driven by their expertise, entrepreneurial spirit, and passion, its teamof experienced investment managers and startup experts help guide the development of young companies. HTGF’s focus is on high-tech startups in a range of sectors, including software, media, internet, hardware, automation, health care, chemistry, and life sciences.To date, external investors have injected over EUR 2 billion into the HTGF portfolio via about 1,400 follow-on financing rounds. HTGF has also successfully sold interests in more than 100 companies. Investors in this public-private partnership include the Federal Ministry For Economic Affairs and Energy, the KfW Banking Group, and Fraunhofer-Gesellschaft e.V., as well as the companies ALTANA, BASF, BAYER, B.Braun, Boehringer Ingelheim, Robert Bosch, BÜFA, CEWE, Deutsche Post DHL, Dräger, Drillisch AG, EVONIK, EWE AG, FOND OF Haniel, Hettich, Knauf, Körber, LANXESS, media + more venture Beteiligungs GmbH & Co. KG, PHOENIX CONTACT, Postbank, QIAGEN, RWE Generation SE, SAP, Schufa, Schwarz Gruppe, STIHL, Thüga, Vector Informatik, WACKER and Wilh. Werhahn KG.

Show more...

Investment focus

  • Industry: Software, Information Technology, Biotechnology
  • Stage:Seed, Series A
  • Geography: Germany, Switzerland, United States

Investor stats

  • Total investments: 373
  • Round size: Seed $665k–$5.1M; Series A $1.5M–$16M
  • Lead/follow: 31% lead, 69% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Inovedis — Inovedis offers innovative solutions in medical technology that contribute both to optimized patient care as well as time and cost reductions in the healthcare sector.
  • Resourcify — Mein Recycling is developed by Resourcify GmbH from Hamburg. The app is the easiest solution for businesses to easily manage all of their waste, collections, and recyclers in one app, and for waste management companies to seamlessly connect with their customers online. Their vision is zero-waste: enabled with the digital transformation of the wastesector as the foundation for the circular economy.
  • traceless materials — traceless materials offer a holistically sustainable alternative to plastics: 100% biobased on plant residues, compostable under natural conditions, and free of toxic chemicals. For a future free of pollution and waste!
Show all investments...

HealthTech Capital
VC Fund · Los Altos Hills, California, United States · 17 investments in Medical Device startups

Private angel investors and corporate venture ecosystem investing in healthtech, digital health and other healthcare technologies startups

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Seed, Series A, Convertible Note
  • Geography: United States

Investor stats

  • Total investments: 83
  • Round size: Seed $1M–$3.4M; Series A $1.6M–$11M
  • Lead/follow: 12% lead, 88% follow

Portfolio highlights

  • Agile Therapeutics — Agile Therapeutics, Inc., a specialty pharmaceutical company, engages in the development of women's healthcare products. It offers a low estrogen dose seven-day transdermal contraceptive patch system that delivers a combination of levonorgestrel and Ethinylestradiol. The company was founded in 1997 as Levotech, Inc. and changed its name toAgile Therapeutics, Inc. in April 2001. It is based in Princeton, New Jersey.
  • GT Metabolic Solutions — GT Metabolic Solutions has developed minimally-invasive incisionless bypass technology for bariatric, metabolic and digestive surgery.
  • Wavely Diagnostics — Wavely Diagnostics is pioneering the future of remote digital diagnostics and enabling telehealth growth by leveraging smartphone technology to address pediatric care.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
MB Venture Partners
VC Fund · Memphis, Tennessee, United States · 17 investments in Medical Device startups

MB Venture Partners in Memphis, TN provides venture capital for life sciences: medical device, biotechnology companies, products for musculoskeletal diseases

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Series B, Series C
  • Geography: United States, Israel

Investor stats

  • Total investments: 90
  • Round size: Seed $50k–$700k; Series B $1.3M–$18M; Series C $5M–$28M
  • Lead/follow: 9% lead, 91% follow
  • Last fund: May invest from a new fund soon — last raise in 2011

Portfolio highlights

  • Cast21 — The future of orthopedic technology has arrived. Cast21 braces are designed for your active lifestyle.
  • SweetBio — SweetBio is a Memphis, Tennessee based medical device company specializing in bioengineering honey-incorporated materials for wound care.
  • Lineus Medical — Lineus Medical is a medical device company focused on reducing IV complications for patients and providers all over the world.
Show all investments...

EIT Health
VC Fund · Munich, Bayern, Germany · 16 investments in Medical Device startups

EIT Health is a network of best-in-class health innovators backed by the EU. We deliver solutions to enable European citizens to live longer, healthier lives.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Grant, Pre-Seed, Seed
  • Geography: United Kingdom, Spain, Ireland

Investor stats

  • Total investments: 90
  • Round size: Seed $536k–$1.4M; Grant $21k–$1.2M; Pre-Seed $43k–$1.4M
  • Lead/follow: 59% lead, 41% follow

Portfolio highlights

  • Ochre Bio — Ochre Bio is developing therapies for the biggest liver health challenges.
  • ZiO Health — ZiO Health develops multi-functional electronic devices for measuring, testing and detecting the molecular composition of chemical and biological substances for the presence, absence, or quantity of target molecules.
  • Nanordica Medical — Nanordica Medical develops novel nanoparticle-based antibacterial wound care products.
Show all investments...

Oxford Finance LLC
VC Fund · Alexandria, Virginia, United States · 16 investments in Medical Device startups

Providing Flexible and Creative Financial Solutions to Life Sciences and Healthcare Services Companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Debt Financing, Post-IPO Debt, Series B
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 111
  • Round size: Post-IPO Debt $15M–$100M; Debt Financing $5M–$60M
  • Lead/follow: 47% lead, 53% follow

Portfolio highlights

  • Renibus Therapeutics — Renibus Therapeutics operates in the healthcare industry focusing on the pharmaceutical business. The company was incorporated in 2015 and is based in Lantana, Texas.
  • ALX Oncology — ALX Oncology is a preclinical stage biotechnology company developing innovative immuno-oncology therapies for cancer. It is an independent, private biotechnology company.The founding of Alexo Therapeutics was based upon technology invented by Aaron Ring, K. Christopher Garcia, Kipp Weiskopf, Aron Levin, and Irving Weissman at Stanford University.This discovery involves soluble versions of signal regulatory protein-α (SIRPα) that have been engineered to bind CD47 with significantly greater affinity than natural SIRPα.1.
  • Pearl Street Dental Management — Pearl Street Dental Management supports non-clinical operations. They provide centralized services such as human resources, payroll, accounting, bookkeeping, finance, lending, facilities management, and information technology services. They address inquiries through online applications, phone calls, and emails.
Show all investments...

Khosla Ventures
VC Fund · Menlo Park, California, United States · 16 investments in Medical Device startups, 40 in the past 12 months

Khosla Ventures is a venture capital firm started in 2004 by Vinod Khosla, Co-Founder of Sun Microsystems. The firm provides venture assistance and strategic advice to entrepreneurs working on breakthrough technologies.With over $15b assets under management, the firm focuses on a range of areas including consumer, enterprise, education,advertising, financial services, semiconductors, health, big data, agriculture, food, sustainable energy, and robotics. Khosla Ventures is headquartered in Menlo Park, California.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series A, Series B, Seed
  • Geography: United States, India, United Kingdom

Investor stats

  • Total investments: 743
  • Round size: Seed $1.5M–$7M; Series A $4.3M–$26M; Series B $8M–$60M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Arkifi — Arkifi is an artificial intelligence company that develops AI-powered financial analyst tools. Arkifi's framework generates consistent results that avoid fabricating factual details (referred to as "hallucination"), instilling enterprises with an unmatched level of confidence in the outcomes.
  • Teamshares — One hundred percent close rate on LOIs. Committed capital with no financing contingency. Teamshares is the buyer of choice for your business listing. Request a buyer profile to learn more about us.
  • Alias Technologies — Here at Alias Technologies our goal is to help organizations tackle complex IT goals and initiatives in an ever-changing landscape. Leveraging our Partner relationships and extensive experience we are able to help position our customers for the future.
Show all investments...

North Coast Ventures
VC Fund · Cleveland, Ohio, United States · 16 investments in Medical Device startups

North Coast Ventures (formerly North Coast Angel Fund) is comprised of four contributed capital funds with a focus on early-stage technology investments. Our membership consists of a number of Ohio's leading investors, entrepreneurs, and business leaders who are dedicated to accelerating early-stage ventures.North Coast Ventures members playan active role by generating deal flow, serving on due diligence teams, working with portfolio companies, or serving on the Investment Screening and Executive Committees. Through this involvement, our goal is to provide a supportive environment for our portfolio companies and ultimately enhance the performance of our Fund.Northeast Ohio has a long tradition of active and successful angel investing, but until recently, the success of this crucial form of funding has hinged on the efforts of a relatively small number of individual investors. As the region’s first professionally managed angel fund, North Coast Angel Fund works to improve the early-stage funding environment for both entrepreneurs and investors.

Show more...

Investment focus

  • Industry: Health Care, Software, Medical Device
  • Stage:Series A, Seed
  • Geography: United States

Investor stats

  • Total investments: 86
  • Round size: Seed $250k–$3M; Series A $500k–$20M
  • Lead/follow: 18% lead, 82% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • UnifyWork — UnifyWork's skills-based matching technology creates a faster way for employers to hire qualified talent, and helps job seekers find job opportunities meeting their skills and interests.
  • Bloomfilter — Bloomfilter is a developer of an enterprise software planning application. Bloomfilter helps software executives and leaders illuminate the path to software project success through our platform.
  • Vytalize Health — Vytalize Health is an all-in-one solution for independent primary care physicians participating in value-based care with Medicare. Vytalize integrates with physicians through people, technology, and unique value-based arrangements that result in better patient outcomes and better optimized care delivery.As of 2021, the company has 600+ PCPs,65K Medicare patients, and $1B in medical spending.
Show all investments...

Parkwalk Advisors
VC Fund · London, England, United Kingdom · 16 investments in Medical Device startups, 12 in the past 12 months

Parkwalk is a London-based fund management firm. Parkwalk invests in UK technology companies that have IP backing and freedom to operate, generally spun out of UK universities. Their funds seek to generate capital gains for their investors, enhanced by the attractive tax relief provided by EIS. Parkwalk entered this investment sector in 2009,anticipating a wave of tax-efficient incentives launched by the UK Government to stimulate innovative emerging technology companies and thereby help drive economic growth.Parkwalk utilises academic, technology transfer, venture capital and personal networks developed over many years to gain access to the highest calibre deal-flow. In 2017 Parkwalk joined forces with IP Group plc, a leading intellectual property commercialisation company that is listed on the Main Market of the London Stock Exchange under the ticker symbol IPO. As at March 2019 the combined group has net assets of £1.2bn.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Seed, Series A, Series B
  • Geography: United Kingdom, United States, Philippines

Investor stats

  • Total investments: 211
  • Round size: Seed $860k–$3.7M; Series A $1.5M–$12M; Series B $1.8M–$33M
  • Lead/follow: 26% lead, 74% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • RoboK — A Cambridge University spin-out building cost-effective 3D sensing software technology
  • Mogrify — Mogrify is pioneering a new class of in vivo reprogramming therapy and transforming the development of ex vivo cell therapy.
  • PharmEnable — Designing the next generation of small molecule drugs. Replicating the specificity of biologics in the scalable form of a small molecule.
Show all investments...

Sofinnova Partners
VC Fund · Paris, Ile-de-France, France · 15 investments in Medical Device startups, 21 in the past 12 months

Sofinnova Partners is a leading European venture capital firm in life sciences, specializing in healthcare and sustainability. Based in Paris, London and Milan, the firm brings together a team of professionals from all over the world with strong scientific, medical and business expertise.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: France, United States, United Kingdom

Investor stats

  • Total investments: 232
  • Round size: Series A $4.4M–$53M; Series B $7M–$57M; Series C $10M–$54M
  • Lead/follow: 47% lead, 53% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Crescendo Biologics — Crescendo Biologics is a new Cambridge-based company whose vision is to deliver next-generation antibody therapeutics based on novel class-leading platforms.The focus of the company is on developing platforms that will address key issues in generating high-affinity, soluble, human VH antibody fragments. These are the smallest fragments thatretain antibody binding, and have many desirable properties as potential therapeutics. Crescendo will then utilise these platforms for product development of in-house targets or in partnership with other companies.
  • Sitryx Therapeutics — Sitryx is a biopharmaceutical company focused on regulating cell metabolism to develop first-in-class disease modifying therapeutics in immuno-oncology and immuno-inflammation. The company was co-founded by a team of world-leading scientists from the United States and Europe who have contributed significantly to the field of immunometabolism.Sitryx was founded in 2018 with seed funding from SV Health Investors and raised $30 million Series A funding from an international syndicate of specialist investors including SV Health Investors, Sofinnova Partners, Longwood Fund and GSK. The company has a pipeline of projects at multiple stages of drug discovery. Sitryx is headquartered in Oxford, UK.
  • Tenpoint Therapeutics — Tenpoint Therapeutics is a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Show all investments...

Wavemaker 360
VC Fund · Pasadena, California, United States · 15 investments in Medical Device startups, 6 in the past 12 months

Wavemaker Three-Sixty Health is the leading U.S. early-stage (Seed and following on at the Series A) venture capital fund focused 100% on healthcare. Launched in 2018, Wavemaker 360 invested into the most promising healthcare startups in North America, with LPs from every sector of the US healthcare system. We are SEEDING HEALTHCARE'STOMORROW. We invest in healthcare disruptors and entrepreneurs that see how the industry is transforming itself and want to make a big difference.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Series A
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 66
  • Round size: Seed $250k–$6M; Series A $100k–$24M
  • Lead/follow: 14% lead, 86% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • 32Co — 32Co is a medical technology platform that helps general dentists deliver clear aligner orthodontics to their patients.
  • Essenvia — Rapidly submit eSTAR, EUMDR and IVDR applications, eliminate errors and accelerate approvals with the only regulatory submission platform made for MedTech
  • Gradient Health — One of the biggest barriers to accelerating AI development is access to large datasets of labeled pathologies.
Show all investments...

Texas HALO Fund
VC Fund · Houston, Texas, United States · 15 investments in Medical Device startups

Early Stage Venture Investments

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Software
  • Stage:Seed, Convertible Note, Series A
  • Geography: United States, Canada, Hungary

Investor stats

  • Total investments: 92
  • Round size: Seed $105k–$3M; Series A $3M–$10M
  • Lead/follow: 9% lead, 91% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Flourish Collective — FlourishFund is a digital platform that empowers and supports new and expecting families. The platform consists of two parts: a marketplace with evidence-based goods and vetted maternal wellness services and a funding mechanism for friends and families to contribute to a positive birth and parenting journey.
  • Drusolv Therapeutics — Drusolv Therapeutics is a clinical-stage drug company developing a novel, high-dose statin for early intervention in age-related macular degeneration. Their product ocustatin is aimed at patients who are still in the intermediate stage of the disease and currently have very limited options to prevent progression to late-stage vision loss. Ocustatinwas developed at Harvard University and has been validated in a very successful proof-of-concept clinical trial that showed a 75% reduction in progression to late-stage blindness. John Edwards, the founder and CEO of Drusolv, is a serial entrepreneur with extensive experience in AMD.
  • Vartega — Vartega is a technology development company specializing in the carbon fiber-reinforced plastic recycling process. We have developed alternative technology, processes, and equipment to provide low-cost carbon fiber for use in mass market applications.
Show all investments...

Maine Angels
VC Fund · Portland, Maine, United States · 14 investments in Medical Device startups

Maine Angels they make investments with entrepreneurs with an emphasis on businesses.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Seed, Series A
  • Geography: United States

Investor stats

  • Total investments: 113
  • Round size: Seed $25k–$583k; Series A $662k–$5.9M
  • Lead/follow: 1% lead, 99% follow

Portfolio highlights

  • HighByte — HighByte is an industrial software development company in Portland, Maine building solutions that address the data architecture and security challenges created by Industry 4.0.
  • TOP the organic project — 100% Organic Cotton Period Care. Organic Tampons, Pads, First Period Kit & Bulk Period Products. Women-owned, eco-friendly, plant-based and sustainable. With every subscription, TOP gives back to women in need.
  • Pumpspotting — connect over breastfeeding, milk, motherhood, and the best places to nurse and pump. nurse, pump, nourish, connect.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Good Growth Capital
VC Fund · Charleston, South Carolina, United States · 14 investments in Medical Device startups, 11 in the past 12 months

Good Growth Capital specializes in finding, cultivating, and assessing complex science and deep-tech start-ups. GGC invests in seed-stage and Series A deals through the General Fund family and in pre-seed and seed-stage companies through the Infinite Corridor Fund, which primarily targets MIT-affiliated and transformative science start-ups. GGC ismajority women- and minority-owned and is uniquely positioned geographically in both the Southeast and New England.

Show more...

Investment focus

  • Industry: Health Care, Information Technology, Software
  • Stage:Seed, Convertible Note, Series A
  • Geography: United States, France, Israel

Investor stats

  • Total investments: 90
  • Round size: Seed $350k–$4.1M; Series A $4.2M–$24M; Convertible Note $25k–$300k
  • Lead/follow: 40% lead, 60% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • Pryon — Pryon is the leading AI-as-a-Service platform for content and knowledge management. Pryon closes knowledge gaps, improving employee productivity, and enhancing customer experiences. Companies such as Georgia Pacific use Pryon to improve health and safety outcomes, eliminate compliance incidents, improve employee onboarding, and upgrade all aspectsof customer service and support.
  • VenoStent — VenoStent is a clinical-stage tissue engineering company that’s developed tunable, bioabsorbable smart polymer wraps in order to fundamentally transform the 5 million vascular surgeries performed each year.
  • Lemurian Labs — Lemurian Labs develops disruptive, highly parallel, ultra low-power inner-product architecture to make deep learning and computer vision applications on the edge, sustainable, resulting in higher inference throughput, a reduction in energy consumed and a decrease in heat generated from chip processing
Show all investments...

Mercia Fund Managers
VC Fund · Henley In Arden, Warwickshire, United Kingdom · 14 investments in Medical Device startups, 8 in the past 12 months

Mercia Asset Management provides equity and debt to UK businesses with growth ambition. We are your investment partners from scale-up to exit.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, Hungary

Investor stats

  • Total investments: 119
  • Round size: Seed $184k–$1.8M; Series A $1.2M–$21M
  • Lead/follow: 69% lead, 31% follow
  • Last fund: May invest from a new fund soon — last raise in 2013

Portfolio highlights

  • CanSense — CanSense is a developer of an inexpensive and scalable blood test intended for early diagnosis of bowel cancer.
  • Workbuzz — Issue employee engagement surveys with WorkBuzz - a fast, simple, and flexible platform with expert consultancy. Try it now!
  • Centuro Global — Centuro Global helps you go global.We help startups, scaleups & corporates enter new markets around the world. All your international expansion needs are serviced from one platform, whether you need legal support, tax & accounting, HR, opening a bank account or finding office space, we can assist across the board.Our innovativeplatform, Centuro Connect, contains blueprints on how to do business in over 150 countries, provides live chat advice, and access to local experts around the world. Instead of losing time undertaking Google searches for relevant information and identifying trusted, cost-effective service providers, find all your solutions through Centuro Connect.Come to us for services including; Legal, Immigration, Intellectual Property, Scaling & Expansion, New Market Entry, Tax & Accounting and much more.Receive advice, find service providers, investors and like minded individuals, and seamlessly grow your business.Book a free consultation with us: www.centuroglobal.com
Show all investments...

Bpifrance
VC Fund · Maisons-alfort, Ile-de-France, France · 14 investments in Medical Device startups, 117 in the past 12 months

Bpifrance provides financial solutions for companies that are booting up the listing on the stock exchange and credit equity. It includes OSEO, CDC Entreprises, FSI, and FSI Regions to offer in your area of financial solutions at every stage of the life of your business.Bpifrance was founded in 2012 and is based in Maisons-alfort, Ile-de-France,France.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Seed, Series A
  • Geography: France, United States, Switzerland

Investor stats

  • Total investments: 667
  • Round size: Seed $643k–$5.4M; Series A $2M–$29M
  • Lead/follow: 22% lead, 78% follow
  • Last fund: Likely still investing — fund raised in 2021

Portfolio highlights

  • Nonna Lab — Make the Most. Le laboratoire qui vous rend la vie meilleure.
  • Altior — Altior is an IT company that offers cloud industrial management software and ERP solution.
  • Umiami — Umiami Technologies is a leader in plant-based meat. Our proprietary technology allows us to create clean-label and incredibly tasty foods.
Show all investments...

VI Partners
VC Fund · Altendorf, Schwyz, Switzerland · 14 investments in Medical Device startups

VI Partners are Venture Capitalists successfully financing outstanding teams and innovations in the Healthcare and Technology space since 20 years.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Series A, Series C, Series B
  • Geography: Switzerland, Germany, United States

Investor stats

  • Total investments: 96
  • Round size: Series A $3.3M–$24M; Series B $3.2M–$36M; Series C $7M–$100M
  • Lead/follow: 20% lead, 80% follow
  • Last fund: May invest from a new fund soon — raised $119M in 2020

Portfolio highlights

  • Vara — Vara develops a breast cancer screening platform powered by AI for radiologists, allowing them to focus on finding cancer early. While we provide. Vara also provides remote mammography reading services to those that lack the radiologists. Vara's mission is to make affordable diagnostics available all over the world by designing machinelearning-powered workflows that users love to work with.
  • Oculis — The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME(diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. Furthermore, the technique has been demonstrated to allow diseases at the anterior part of the eye to be treated with a reduced number of topical applications compared to conventional eye-drops.
  • Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
Show all investments...

Horizon Technology Finance
VC Fund · Farmington, Connecticut, United States · 14 investments in Medical Device startups

Horizon is a venture lending platform that offers structured debt products to life science and technology companies. Its team of investment and operations professionals has been providing debt capital to some of the most exciting companies for decades. The members of the Horizon team have, collectively, originated and invested more than $5 billionin venture loans to thousands of companies.The company was founded in 2003 and is headquartered in Farmington, Connecticut.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical Device
  • Stage:Debt Financing, Post-IPO Debt
  • Geography: United States, Canada, India

Investor stats

  • Total investments: 89
  • Round size: Post-IPO Debt $10M–$40M; Debt Financing $5M–$25M
  • Lead/follow: 64% lead, 36% follow
  • Last fund: May invest from a new fund soon — last raise in 2018

Portfolio highlights

  • Unagi Scooters — Unagi is an electric scooter startup that aims to liberate people from the tyranny of transportation frustrations—the costs, inconveniences, the carbon emissions. So we built the ideal personal liberation device.
  • Evelo Biosciences — Evelo Biosciences is dedicated to improving the lives of patients globally through the development of a new modality of medicines – monoclonal microbials. Monoclonal microbials are orally delivered medicines that modulate systemic immunology and biology through direct interactions with human cells in the gut. These new medicines are broadlyapplicable across many diseases – including autoimmune, immunoinflammatory, metabolic, neurological, neuroinflammatory diseases and cancer. Monoclonal microbials have the potential to fundamentally change traditional models of drug discovery and development. By finding and selecting naturally occurring monoclonal microbials with defined therapeutic effects, Evelo can improve the speed, cost and success of drug discovery and development. Evelo’s platform enables pharmacological intervention at all stages of disease with naturally occurring, safe and effective monoclonal microbials. Evelo Biosciences was conceived and created within VentureLabs®, Flagship Pioneering’s institutional innovation foundry, and launched by Flagship in 2015.
  • Slingshot Aerospace — Slingshot Aerospace applies advanced analytics, machine learning, and collaborative tools to data from earth and space, providing clarity in complex environments.
Show all investments...

Versant Ventures
VC Fund · Menlo Park, California, United States · 14 investments in Medical Device startups, 7 in the past 12 months

Versant partners with exceptional entrepreneurs to build and fund breakthrough biotechnology companies around the globe.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States, Switzerland, Canada

Investor stats

  • Total investments: 253
  • Round size: Series A $3.9M–$68M; Series B $6M–$85M; Series C $6M–$80M
  • Lead/follow: 27% lead, 73% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Kate Therapeutics — Kate Therapeutics is a patient-focused biotechnology company developing AAV-based gene therapies to treat genetically defined muscle and heart diseases.
  • Nexo Therapeutics — Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies.
  • Tentarix Biotherapeutics — Tentarix creates innovative protein therapeutics with uniquely combined bioactivities that leverage synthetic biology. The company develops a protein engineering platform designed for multispecific therapies.
Show all investments...

Arboretum Ventures
VC Fund · Ann Arbor, Michigan, United States · 14 investments in Medical Device startups

For over 20 years we have been a successful healthcare venture capital firm rooted in the Midwest. Check out our portfolio companies.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, Canada

Investor stats

  • Total investments: 93
  • Round size: Series A $4.4M–$23M; Series B $5M–$55M; Series C $3M–$90M
  • Lead/follow: 42% lead, 58% follow
  • Last fund: May invest from a new fund soon — raised $250M in 2019

Portfolio highlights

  • BrightSpec — LabBrightSpec addresses high-value, time-sensitive analytical chemistry challenges that are not well addressed by other spectroscopy techniques and instruments. It provides innovative laboratory services in order to deliver immediate results to potential customers of our instrumentation products. They are based in Charlottesville, Virginia,about two hours from Washington, DC. The BrightSpec Fourier transform molecular rotational resonance (FT-MRR) product platform is based on technology developed at the University of Virginia by Brooks Pate and his team, several of whom now work at BrightSpec. They offer FT-MRR product configurations for analytical chemistry and gas sensing in manufacturing process control, quality control, environmental monitoring, and formulation research.
  • Boomerang Medical — Boomerang Medical is a bioelectronic medicine company targeting autoimmune diseases.
  • Enumera Molecular — Enumera Molecular is a life science tools company headquartered in Ann Arbor, MI, developing a scalable biomolecule assessment platform enabling lower-cost, rapid clinical liquid biopsy tests. It helps in transforming the field of clinical molecular testing into a simpler, more actionable tool for physicians to benefit patient care.
Show all investments...

U.S. Venture Partners
VC Fund · Menlo Park, California, United States · 13 investments in Medical Device startups, 10 in the past 12 months

U.S. Venture Partners (USVP) is a venture capital partnership, helping entrepreneurs transform their ideas and efforts into world-changing companies. The firm focuses on early-stage ventures in information technology and health care, where innovation is unbridled and has led to the creation of economic wealth and millions of jobs over the pastthirty-plus years of the firm's existence. Areas of particular interest to our investment professionals include enterprise software, IT security, consumer internet, mobile, and e-commerce, healthcare, and IT-enabled healthcare services. The USVP team consists of former entrepreneurs, technologists, corporate executives, financial professionals, and industry domain experts.

Show more...

Investment focus

  • Industry: Software, Health Care, Information Technology
  • Stage:Series B, Series C, Series A
  • Geography: United States, Israel, Canada

Investor stats

  • Total investments: 353
  • Round size: Series A $5M–$31M; Series B $7.1M–$50M; Series C $8.5M–$65M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Percepto — Percepto is a developer of autonomous drone technology for inspection and surveillance.Drones hold the potential to disrupt multi-billion dollar industries including energy, security, insurance, agriculture, and more. Drones completely change the way inspection, measurement, surveillance, and deliveries are done today. Still, the main barrier tomaking them a must-have platform is the ability of drones to perform tasks autonomously.The company is at the forefront of redefining how industrial sites and critical infrastructure are holistically inspected and monitored, harnessing remote robotics to autonomously collect, aggregate, and analyze visual data.Leveraging its experience with Percepto Sparrow, the most deployed drone-in-a-box solution on the market, Percepto introduced Percepto AIM (Autonomous Inspection and Monitoring) the first end-to-end autonomous inspection and monitoring platform. Percepto AIM empowers the remote operation center of the future to assess risk, minimize downtime, drive efficiency, increase safety, and reduce operational costs.
  • Trust Lab — Trust Lab develops solutions to detect and mitigate online safety threats and works with social media companies, advocacy groups, and other interested parties to implement them. Palo Alto, California, U.S.A.
  • Luminopia — Luminopia is pioneering a new class of treatments for significant neuro-visual disorders. Luminopia is committed to creating digital therapeutics that are both rigorously evaluated for FDA approval and genuinely engaging for patients. As an Innovation Partner of Boston Children’s Hospital, the company is developing its lead product, Luminopia One,to treat amblyopia, the leading cause of vision loss among children. For more information, visit luminopia.com.
Show all investments...

Kurma Partners
VC Fund · Paris, Ile-de-France, France · 13 investments in Medical Device startups

Kurma Partners is a management company based in Paris, specializing in the financing of innovation in healthcare and biotechnology, from pre-creation to development capital. Kurma Partners, which manages the Kurma Biofund I, II funds and the Kurma Diagnostics fund, is one of the main players in the financing of therapeutic and medical innovationsin Europe, particularly through links with many institutes. research and prestigious hospitals.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Series B
  • Geography: France, Spain, Switzerland

Investor stats

  • Total investments: 95
  • Round size: Seed $2.1M–$7.5M; Series A $2.1M–$50M; Series B $4.1M–$80M
  • Lead/follow: 53% lead, 47% follow
  • Last fund: May invest from a new fund soon — raised $89M in 2020

Portfolio highlights

  • Xeltis — Xeltis is pioneering a restorative approach in cardiovascular therapy.
  • Axithra — Saving lives and improving health economics through significant advancement of therapeutic drug monitoring (TDM).
  • Kiro — Kiro is an IT company that offers artificial intelligence, ergonomic design, and software development solutions for medical biology.
Show all investments...

Ben Franklin Technology Partners of Southeastern Pennsylvania
VC Fund · Philadelphia, Pennsylvania, United States · 13 investments in Medical Device startups

We’re (not just) investors.We’re (more than) advisors.We’re (beyond) connectors.Ben Franklin Technology Partners combines the best practices of early stage investing with a higher purpose – to lead the region’s technology community to new heights, creating jobs and transforming lives. For over 30 years, Ben has been the leading seedstage capital provider for the region’s technology sectors, investing over $170 million in more than 1,750 regional technology companies, many of which have gone on to become industry leaders. Ben Franklin has also launched university/industry partnerships that accelerate scientific discoveries to commercialization, and has seeded regional initiatives that strengthen our entrepreneurial community.

Show more...

Investment focus

  • Industry: Health Care, Software, Information Technology
  • Stage:Seed, Grant, Debt Financing
  • Geography: United States

Investor stats

  • Total investments: 134
  • Round size: Seed $50k–$1.6M; Grant $5k–$100k; Debt Financing $975k–$975k
  • Lead/follow: 40% lead, 60% follow

Portfolio highlights

  • Yellowdig — Yellowdig offers educators a gameful learning digital solution to improve student engagement by building learning communities.
  • ImpactableX — The social impact modeling & management toolkit behind leading solutions to our world's most pressing challenges.
  • GrowFlux — GrowFlux, Inc. they offers a ecosystem of commercial scale wireless lighting controls, cloud services, and cloud connected agricultural sensors.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Foundation for Technological Innovation (FIT)
VC Fund · Lausanne, Vaud, Switzerland · 13 investments in Medical Device startups, 7 in the past 12 months

The Foundation for Technological Innovation (FIT) has been helping startups since 1994, encourages entrepreneurship & supports innovation.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Information Technology
  • Stage:Debt Financing, Grant, Seed
  • Geography: Switzerland, France

Investor stats

  • Total investments: 117
  • Round size: Seed $111k–$111k; Grant $22k–$111k; Debt Financing $111k–$555k
  • Lead/follow: 95% lead, 5% follow

Portfolio highlights

  • Voltiris — Voltiris filters natural sunlight to transmit it to plants and recycle the "wasted" sunlight into green electricity.
  • PeriVision — Perivision combines artificial intelligence, virtual reality, and the cloud to build the next generation of systems to understand visual function. The company's systems improve workflow efficiency in practices and hospitals and provide deeper clinical insight into eye diseases.
  • AdVentura Works — AdVentura Works is a Swiss technology company offering material handing as a service to logistics and industrial companies
Show all investments...

TEDCO
VC Fund · Columbia, Maryland, United States · 13 investments in Medical Device startups, 11 in the past 12 months

TEDCO was created by the Maryland State Legislature in 1998 to facilitate the transfer and commercialization of technology from Maryland’s research universities and federal labs into the marketplace and to assist in the creation and growth of technology-based businesses in all regions of the State. TEDCO is an independent organization thatstrives to be Maryland’s lead source for entrepreneurial business assistance and seed funding for the development of startup companies in Maryland’s innovation economy. In Maryland and beyond, TEDCO is a resource of mentoring, funding and networking for entrepreneurs and start-ups that need guidance as they bring innovative concepts to market. TEDCO is more than an early stage funding resource. It is the hub of Maryland’s entrepreneurial network where startups find mentors, organizational assistance, facilities for daily operations, and a roadmap for success.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Pre-Seed, Series A
  • Geography: United States

Investor stats

  • Total investments: 131
  • Round size: Seed $100k–$2.5M; Pre-Seed $25k–$1.1M; Series A $80k–$5M
  • Lead/follow: 39% lead, 61% follow

Portfolio highlights

  • Hopr — Hopr recognizes the increasing relevance of cybersecurity in today's global digital society. Hopr objective is to assist organizations in protecting their digital operations and data by rethinking old challenges and then developing innovative cybersecurity solutions to tackle them.
  • Fem Equity — Fem Equity is a work platform that develops real-time solutions for women and underrepresented professionals experiencing salary or professional inequalities.
  • N5 Sensors — Sensors and solutions for protecting lives and infrastructure from environmental hazards.
Show all investments...

Sand Hill Angels
VC Fund · Mountain View, California, United States · 13 investments in Medical Device startups, 7 in the past 12 months

For over two decades, Sand Hill Angels has worked openly and collaboratively with venture capital funds, other angel organizations, and the Bay Area ecosystem that fosters the growth of technology startups.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Seed, Series B, Series A
  • Geography: United States, Canada, Japan

Investor stats

  • Total investments: 198
  • Round size: Seed $1M–$6.2M; Series A $1.1M–$8M; Series B $6.8M–$35M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • GaeaStar — The zero waste disposable clay cups. GaeaStar is an engineering company developing sustainable single use products and technology.
  • MOGL — MOGL is created for athletes by athletes. The platform empowers all athletes to seek out opportunities to monetize their name, image, and likeness in a safe...
  • PrivacyHawk — Privacyhawk is a mobile app that empowers everyone to take back control of their privacy.
Show all investments...

Silicon Valley Bank
VC Fund · Santa Clara, California, United States · 13 investments in Medical Device startups, 38 in the past 12 months

Silicon Valley Bank works with technology, life science, cleantech, venture capital, private equity, and premium wine businesses. SVB provides industry knowledge and connections, financing, treasury management, corporate investment, and international banking services to its clients worldwide through 27 U.S. offices and seven internationaloperations. Banking innovative companies and exclusive wineries, Silicon Valley Bank’s diverse financial services, knowledge, global network, and world-class service increase its clients’ probability of success. Forbes Magazine ranks SVB among America’s Best Banks, and Fortune Magazine named SVB one of the Best Companies to Work For in 2012.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Debt Financing, Series B, Series A
  • Geography: United States, United Kingdom, Canada

Investor stats

  • Total investments: 374
  • Round size: Series A $4M–$30M; Series B $5.5M–$42M; Debt Financing $5M–$145M
  • Lead/follow: 28% lead, 72% follow
  • Last fund: May invest from a new fund soon — last raise in 2016

Portfolio highlights

  • SafeRide Health — SafeRide Health provides technology-forward non-emergency medical transportation (NEMT) services for care providers and health plans offering Medicare Advantage and Medicaid. We intelligently improve and simplify NEMT to improve health outcomes and healthcare satisfaction.
  • Rainforest — Rainforest focuses on providing software platforms for payment processing. Rainforest is headquartered in Atlanta, United States.
  • Olema Oncology — At Olema Oncology, we leverage our deep understanding of endocrine-driven cancers, nuclear receptors and mechanisms of acquired resistance with the goal of transforming the standard of care for women living with cancer by focusing on developing more convenient and effective therapies. Join us as we aim to design therapies for improving lives.
Show all investments...

Wisconsin Investment Partners
VC Fund · Madison, Wisconsin, United States · 13 investments in Medical Device startups

Wisconsin Investment Partners is an Angel Investment Group in Madison, Wisconsin founded in 2000 with 20 members.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 108
  • Round size: Seed $134k–$3M; Series A $1.1M–$17M
  • Lead/follow: 15% lead, 85% follow

Portfolio highlights

  • Sequoir — Sequoir is a financial technology firm providing blockchain trading and custody APIs to power banks, credit unions, fintech, and the Web 3.0.
  • Flyte — Flyte promotes cellular healing in pelvic floor muscles for lasting results. Flyte is fast, proven, safe, pelvic floor therapy for bladder control.
  • Nurse Disrupted — A virtual nursing program that retains nurses & improves hospital finances. Live in 4 weeks. Engaged, happier nurses in days.
Show all investments...

Oxford Bioscience Partners
VC Fund · Boston, Massachusetts, United States · 13 investments in Medical Device startups

Bigslot288 merupakan situs slot deposit pulsa 10 ribu tanpa potongan 2022, terbukti sebagai web slot pulsa tanpa potongan terpercaya jaminan taruhan 100% aman.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Pharmaceutical
  • Stage:Series B, Series C, Series A
  • Geography: United States, Germany, Switzerland

Investor stats

  • Total investments: 109
  • Round size: Series A $3.5M–$25M; Series B $12M–$43M; Series C $5.6M–$50M
  • Lead/follow: 13% lead, 87% follow
  • Last fund: May invest from a new fund soon — raised $66M in 2011

Portfolio highlights

  • Paperspace — Ceres, Inc. (Ceres) is an agricultural biotechnology company selling seeds to produce renewable biomass feedstocks. The Company’s large-scale commercial products are sweet sorghum varieties that can be used as a drop-in feedstock to extend the operating season of Brazilian sugarcane-to-ethanol mills. Its products include sweet sorghum, high biomasssorghum, switchgrass, miscanthus and row crops. Its energy crops can also be used for the production of second-generation biofuels and bio-based chemicals, including cellulosic ethanol, butanol, jet fuel, diesel-like molecules and gasoline-like molecules, from non-food biomass. Baseload utility scale electric power can also be generated from the biomass feedstocks grown from its seeds. Ceres has sold switchgrass and high biomass sorghum seeds in the United States under its Blade Energy Crops (Blade) brand. In January 2010, the Company incorporated a subsidiary, Ceres Sementes do Brasil Ltda.
  • CardioFocus — CardioFocus provides electrophysiologists with innovative and effective tools that bring precision and control to the treatment of atrial fibrillation.
  • Yolia Health — Yolia Health developed The True Vision Treatment or TVT, the 'Invisalign' for the eyes. A non-invasive treatment to correct vision problems like presbyopia without surgery. TVT is self-administered by the patient in his or her own home. It employs a combination of customized contact lenses (TVT Contacts) and specially formulatedeye drops (TVT Eye Drops). After only 5 days of treatment with TVT patients are able to stop using the TVT Contacts, TVT Eye Drops and their reading glasses for up to 12 months at a time before re-treatment with TVT is needed. What is even greater than correcting for presbyopia non-invasively, is correcting both eyes without compromising any distance vision. On the contrary, Yolia's treatment improves both near and distance vision, a unique feature no single other alternative can provide. ** Looking for sophisticated investors and key industry partners.
Show all investments...

Seventure Partners
VC Fund · Paris, Ile-de-France, France · 12 investments in Medical Device startups, 7 in the past 12 months

Seventure Partners is a French venture capital firm targeting in information and communication technology, and life sciences companies. It funds innovation and participates in the entrepreneurial adventure, alongside entrepreneurs and sharing their passion.Founded in 1997, Seventure Partners is one of the European leaders in venture capital, with€ 660 million under management as of December 31, 2016. It is an active partner of innovative companies that, according to the management team, show strong growth potential and evolving in two fields of activity: Digital Technologies and Life Sciences. With more than 20 employees, including some 15 investors, Seventure Partners has a proven track record and in-depth expertise in technology, entrepreneurship, and various private equity operations.Seventure's goal is to identify and support the development of tomorrow's European leaders in order to accelerate their growth. To do this, the firm provides entrepreneurs with the expertise, networks, and know-how of its internal team of investors.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B
  • Geography: France, United States, Germany

Investor stats

  • Total investments: 175
  • Round size: Series A $2.4M–$18M; Series B $3M–$35M
  • Lead/follow: 35% lead, 65% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Sinay — Use the full potential of your data with intelligent solutions. Become more efficient on a daily basis and reduce your environmental impact.
  • Allozymes — Allozymes, Pte. Ltd. is a leading deep technology company applying innovative ultrahigh-throughput microfluidics technology to accelerate enzyme evolution and development. We developed sensitive, accurate, and generic assays for the detection of enzymatic reactions, proprietary microfluidic chips and proteomics technologies to take enzymedevelopment to the next level.
  • Vedanta Biosciences — Vedanta Biosciences is a developer of immunotherapies designed to treat immune-mediated and infectious diseases. The company's immunotherapies include a suite of proprietary assays to select pharmacologically potent strains, vast proprietary datasets from human interventional studies, and facilities for cGMP-compliant manufacturing ofrationally-defined bacterial consortia in powder form, enabling physicians to access live bacteria drug to treat autoimmune and inflammatory diseases easily.It was founded in 2010 and is headquartered in Cambridge, Massachusetts.
Show all investments...

Scottish Investment Bank
VC Fund · Glasgow, Glasgow City, United Kingdom · 12 investments in Medical Device startups

Our Entrepreneurship team (formerly the Scottish Investment Bank) helps you find sources of finance, engage with funders and secure investment to grow your business.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Information Technology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States, France

Investor stats

  • Total investments: 195
  • Round size: Seed $307k–$2.5M; Series A $1.5M–$7.6M
  • Lead/follow: 10% lead, 90% follow
  • Last fund: May invest from a new fund soon — last raise in 2015

Portfolio highlights

  • Bio-Images Drug Delivery — BDD Pharma combine drug delivery expertise and clinical capabilities to accelerate product development pipelines, enable life cycle management and new innovative pharmaceutical products. Rapid parallel clinical testing with SWIFT significantly reduces time from product concept to clinical success.
  • IOTech — Discover IOTech Systems, the open edge data platform for developing, deploying, and managing Industrial Edge applications at scale. Find out more here.
  • Administrate — Manage 100% of enterprise training operations with configurable training management software, designed to scale with your organization.
Show all investments...

Catalyst Health Ventures
VC Fund · Braintree, Massachusetts, United States · 12 investments in Medical Device startups

Catalyst Health Ventures is an early-stage venture capital firm targeting technology solutions applied within the health care and life science industries. At the core of this strategy is a committed, hands-on approach to working with management and syndicate partners to build successful companies. Their disciplined investment process leverages bothintellectual and financial capital to originate deals, cultivate opportunities, and realize the full potential of emerging ventures in the health care and life science marketplace. We seek to invest in companies addressing major global unmet clinical needs in areas such as oncology, cardiovascular disease, obesity, and women’s health. We invest in pioneering and proprietary technological solutions fundamentally designed to reduce treatment costs and improve patient outcomes. By investing in solutions which have a technological foundation of engineering and development such as medical devices, diagnostic tools and instrumentation and consumer healthcare, we minimize the risks related to uncertain scientific experimentation.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series A, Series B, Series C
  • Geography: United States

Investor stats

  • Total investments: 36
  • Round size: Series A $1M–$7.8M; Series B $1.8M–$26M; Series C $1.3M–$23M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Epitel — Epilog is an unobtrusive wearable seizure detection system that records long-term EEG, anywhere. It gives people living with epilepsy peace of mind with a much-needed tool to better understand and manage their seizures.
  • Avive Solutions — Check out Avive Solutions, the manufacturers of a brand new AED machine - portable defibrillator - that's FDA approved!
  • PanTher Therapeutics — PanTher Therapeutics is on a mission to revolutionize cancer care with a proprietary treatment platform designed to enhance therapeutic response with minimal side effects. PanTher’s highly adaptable platform empowers oncologists to treat patients with life-threatening cancer by unlocking a drug’s full potential through direct, sustained treatmentat the tumor site. This distinctive targeting capability uniquely positions PanTher to take on the deadliest and most difficult to treat cancers with a lead investigational candidate in pancreatic cancer.
Show all investments...

Mayo Clinic
VC Fund · Rochester, Minnesota, United States · 12 investments in Medical Device startups, 10 in the past 12 months

Mayo Clinic, a not-for-profit medical group practice, provides medical care, research, and education services. It offers medical care services in various specialties, including diabetes and endocrinology, gastroenterology, gynecology, cancer, neurology and neurosurgery, orthopedics, pulmonology, rheumatology, nephrology, urology, and cardiology andheart surgery.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Series B, Seed
  • Geography: United States, Israel, China

Investor stats

  • Total investments: 76
  • Round size: Seed $100k–$5.5M; Series A $3.5M–$26M; Series B $6M–$48M
  • Lead/follow: 17% lead, 83% follow

Portfolio highlights

  • MEDIVIS — Medivis is a leader in AR for healthcare, using augmented reality and artificial intelligence to advance medical imaging and surgical precision.
  • The Contract Network — AI-powered collaborative contracting is an innovative approach to contract negotiation that emphasizes real-time collaboration, communication, and transparency.
  • Collaborative Robotics — Collaborative Robotics is a team of innovators and builders redefining the future of human-robot interaction.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Newable Private Investing
VC Fund · London, England, United Kingdom · 12 investments in Medical Device startups

Newable helps businesses thrive through funding, professional support and premises. Unleashing potential, building resilience & championing growth.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Seed, Series A
  • Geography: United Kingdom, United States

Investor stats

  • Total investments: 100
  • Round size: Seed $184k–$2.9M; Series A $1.2M–$3.8M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Delta g — Delta g Limited is a quantum technology and gravity gradiometry company. A spin-out from the University of Birmingham our technology has applications in industries as varied as civil engineering, infrastructure, defence, rail, navigation and resource exploration. Experts from science, engineering an
  • EarSwitch — Empowering new ways to control and connect with the world through in-ear biometric switch and sensor technology
  • RAB Microfluidics — We diagnose early signs of failure in lubricated machinery and prevent equipment failure using our patented microfluidic technology and AI technology.
Show all investments...

New Enterprise Associates
VC Fund · Menlo Park, California, United States · 12 investments in Medical Device startups, 37 in the past 12 months

New Enterprise Associates, Inc. is a global venture capital firm focused on helping entrepreneurs build transformational businesses across multiple stages, sectors, and geographies. With over $19 billion in cumulative committed capital since the firm’s founding in 1977, NEA invests in technology and healthcare companies at all stages in a company’slifecycle, from seed stage through IPO. The firm's long track record of successful investing includes more than 210 portfolio company IPOs and more than 360 acquisitions.

Show more...

Investment focus

  • Industry: Software, Health Care, Biotechnology
  • Stage:Series B, Series A, Series C
  • Geography: United States, India, China

Investor stats

  • Total investments: 1305
  • Round size: Series A $5M–$43M; Series B $8M–$62M; Series C $11M–$85M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Embrace — Stay informed with Embrace's mobile monitoring solutions. Optimize app performance & user experience with our comprehensive platform. Learn more now.
  • Nexo Therapeutics — Nexo Therapeutics is a small molecule oncology company dedicated to the discovery and development of new drugs for cancer patients who currently lack meaningful therapies.
  • Functional Finance — Automated FinOps for Insurance. Unify and automate all of your financial operations, workflows and servicing without replacing your current infrastructure.
Show all investments...

Verve Ventures
VC Fund · Zug, Zug, Switzerland · 12 investments in Medical Device startups, 16 in the past 12 months

Verve Ventures has invested in more than 140 science and technology startups. We support visionary and resilient entrepreneurs from day one and are a reliable partner for the entire journey. We typically invest EUR 1-3m in early as well as later stage rounds of European high tech startups.

Show more...

Investment focus

  • Industry: Health Care, Software, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: Switzerland, Germany, France

Investor stats

  • Total investments: 200
  • Round size: Seed $911k–$5M; Series A $2.1M–$12M; Series B $4.1M–$18M
  • Lead/follow: 17% lead, 83% follow
  • Last fund: Likely still investing — fund raised in 2022

Portfolio highlights

  • MedTrace Pharma — MedTrace develops a hardware platform (MT-100) that automates the production and injection of the gold standard tracer 15O-water into the patient. MedTrace also develops an analytical software platform to interpret the results from the PET scanner.By use of 15O-water, doctors will increase sensitivity in the analysis of the patient while at thesame time increasing patient throughput up to a factor of 4 compared to today's clinical workhorse.
  • Hylomorph — Hylomorph is a clinical-stage medical device company developing innovative materials designed to transform the biocompatibility of implantable medical devices.
  • Puraffinity — Puraffinity develops targeted materials for water treatment, focused on forever chemicals called PFAS. Our strategic intent is to provide 1 billion people with PFAS safe water by 2030
Show all investments...

Split Rock Partners
VC Fund · Minneapolis, Minnesota, United States · 12 investments in Medical Device startups

Split Rock Partners invests in emerging healthcare, software and Internet services companies in the Upper Midwest and West Coast. They are an early-stage venture capital firm that was founded in June 2004 by the former healthcare and software investment teams of St. Paul Venture Capital (SPVC). The Split Rock team managed over $1 billion of venturecapital during our tenure at SPVC, and continues to manage the SPVC healthcare and software portfolio. In May of 2008, they raised $300 million in the second Split Rock Partners fund, the successor to their inaugural $275 million fund raised in April 2005.The Split Rock team believes that it takes great people to translate promising ideas into compelling businesses. They are grounded in a fundamental respect for entrepreneurs and the rare combination of elements required when pioneering new markets. They start by looking for entrepreneurs with the passion, vision, and skills to build leading companies. They then work with entrepreneurs collaboratively, building partnerships based on integrity and mutual respect. The Split Rock team complements management expertise with over 80 years of venture investing and entrepreneurial management experience. They are proud of the strong relationships they have built with talented entrepreneurs and co-investors throughout their history and look forward to building on that tradition.

Show more...

Investment focus

  • Industry: Health Care, Medical Device, Medical
  • Stage:Series B, Series A, Series C
  • Geography: United States, France

Investor stats

  • Total investments: 104
  • Round size: Series A $3M–$11M; Series B $9M–$21M; Series C $13M–$47M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — last raise in 2008

Portfolio highlights

  • Gravia — More benefits. Fewer asterisks. We are a health benefits company on a mission to build a health plan that everyone can love.
  • EBR Systems — EBR Systems, Inc. is an early-stage development venture pursuing novel approaches in cardiac rhythm management. EBR Systems develops devices for the treatment of cardiac arrhythmias.
  • Gravie — More benefits. Fewer asterisks. We are a health benefits company on a mission to build a health plan that everyone can love.
Show all investments...

Western Development Commission
VC Fund · Ballaghaderreen, Roscommon, Ireland · 12 investments in Medical Device startups

Supporting communities to grow, investing in businesses to scale and planning for the future of the western region.

Show more...

Investment focus

  • Industry: Medical Device, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: Ireland, United States

Investor stats

  • Total investments: 32
  • Round size: Seed $696k–$3.8M; Series A $4.7M–$8M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • ByoWave — ByoWave has developed the Proteus Controller, a modular, accessible video game controller for disabled and non-disabled gamers.
  • Bluedrop Medical — Thermal and visual assessment in a single scan. Award winning, patented design.
  • Amara Therapeutics — Amara Therapeutics is passionate about empowering women and men to take control of their pelvic health. Amara Therapeutics use evidence based medicine and behavioural interventions supported by Amara Therapeutics platform of technologies to provide safe, convenient and non-invasive care pathways. At Amara Therapeutics mission is to fix the carepathway for pelvic health patients, connecting healthcare providers, patients and peers through our platform.
Show all investments...

Innovate Calgary
VC Fund · Calgary, Alberta, Canada · 12 investments in Medical Device startups

Innovate Calgary is a central innovation hub at the University of Calgary. See our programs and fundings and learn more about our innovation hubs here.

Show more...

Investment focus

  • Industry: Health Care, Medical, Medical Device
  • Stage:Seed, Pre-Seed
  • Geography: Canada, United States

Investor stats

  • Total investments: 36
  • Round size: Seed $872k–$1.9M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • MACH32 — MACH32 is a medical device startup that develops innovative solutions for new and longstanding medical problems.
  • InventoRR MD — InventoRR MD focuses on commercializing groundbreaking trauma and general surgery devices that improve patient recovery outcomes, simplify procedures for doctors, and reduce costs for healthcare organizations.
  • Difinity Solutions — Difinity Solutions is specializing in the development of medical devices and technology solutions.
Show all investments...

Green Park & Golf Ventures
VC Fund · Dallas, Texas, United States · 12 investments in Medical Device startups

Green Park & Golf, built on over 50 years of operational and financial experience, seeks investment opportunities that offer above-market returns for its investors. Led by Clay Heighten, M.D., and Carl Soderstrom, the Firm delivers strategic solutions, financial backing and a reliable network to its portfolio companies. The Dallas-based Firm iscurrently looking for investment opportunities in medical-related start-ups.Dr. Heighten founded MedicalEdge Healthcare Group in 1993, and Mr. Soderstrom started PhyServe Physician Services in 1998 to administer the financial and operational needs of MedicalEdge. Together, the companies managed over 550 providers in five major markets. In 2011, the companies were sold to Texas Health Resources, a $3.8 billion health care system. That’s when Green Park & Golf was born.After earning his MBA at Southern Methodist University, Mr. Garcia joined them full-time in May 2011 to actively pursue new investment opportunities and monitor other investments in their portfolio. He has prior professional experience at FedEx, Bold Ventures, and Lone Star Investment Advisors.

Show more...

Investment focus

  • Industry: Health Care, Medical, Biotechnology
  • Stage:Series A, Seed, Series B
  • Geography: United States, Israel, Sweden

Investor stats

  • Total investments: 89
  • Round size: Seed $300k–$1M; Series A $1.3M–$10M; Series B $2.1M–$13M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: May invest from a new fund soon — last raise in 2017

Portfolio highlights

  • Validic — Meet the only EHR-integrated remote care solution delivering personalized care for clinicians and patients, making personal health data actionable.
  • Prolocor — Our goal is to develop a more precise method and diagnostic tool for assessing and managing risk in cardiovascular disease.
  • Worlds — Worlds is completely re-inventing how organizations see and understand their worlds. Through live, AI-powered models, the company’s clients can remotely see, learn and analyze their worlds in ways that were never possible before.
Show all investments...

Life Science Angels
VC Fund · Sunnyvale, California, United States · 12 investments in Medical Device startups

Life Science Angels, Inc. (LSA) is the premier angel investment group focused solely on healthcare investing, including medical devices, diagnostics, pharmaceuticals, biotechnology, and digital health.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Seed, Series A
  • Geography: United States, Israel, The Netherlands

Investor stats

  • Total investments: 78
  • Round size: Seed $605k–$4.1M; Series A $1.3M–$20M
  • Lead/follow: 9% lead, 91% follow

Portfolio highlights

  • InnoSIGN — We are passionate to bring to market our OncoSIGNal pathway activity profiling technology contributing to a better understanding of disease mechanisms in oncology. OncoSIGNal enables next generation precision medicine by translating molecular data into functional cell behavior.
  • Avisi Technologies — Avisi Technologies is developing a nanotechnology-enabled defense against blindness from glaucoma.
  • Astrocyte Pharmaceuticals — Astrocyte Pharmaceuticals Inc. is a privately held drug development company dedicated to accelerating the recovery and well-being of brain injury patients. The company is committed to proving the neuroprotective benefits of selective astrocyte activation, and advancing breakthrough therapeutic agents for treating brain injury resulting from stroke,TBI, concussion, and neurodegenerative disorders such as Alzheimer’s disease.
Show all investments...

Pontifax
VC Fund · Herzliya, Tel Aviv, Israel · 12 investments in Medical Device startups

Pontifax is a healthcare-dedicated venture capital firm.The fund focuses on innovative bio-pharma opportunities.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Israel, France

Investor stats

  • Total investments: 93
  • Round size: Series A $3.8M–$72M; Series B $16M–$100M; Series C $12M–$75M
  • Lead/follow: 23% lead, 77% follow
  • Last fund: May invest from a new fund soon — last raise in 2020

Portfolio highlights

  • Abcuro — Precision Targeting of Highly Cytotoxic T Cells in Autoimmune Disease.
  • Precirix — Developing radio-immunotherapeutic drugs for cancer patients.
  • ARMGO,Pharma,Inc. — ARMGO Pharma, Inc., a biopharmaceutical company, develops small-molecule therapeutics to treat debilitating cardiac, skeletal muscular, and neurological disorders. It offers rycals, which are calcium release channel stabilizers that act on ryanodine receptor/calcium release channel, a therapeutic target located on thesarcoplasmic/endoplasmic reticulum of the cell for treating chronic heart failure, cardiac arrythmias, and muscle disorders, as well as cognitive disorders, malignant hyperthermia, diabetes, chronic obstructive pulmonary disease, high blood pressure, and bladder dysfunction. The company was incorporated in 2004 and is based in Tarrytown, New York with an additional office in New York, New York.
Show all investments...

Hatteras Venture Partners
VC Fund · Durham, North Carolina, United States · 12 investments in Medical Device startups

Hatteras Venture Partners is a venture capital firm based in Research Triangle Park, NC, with a focus on biopharmaceuticals, medical devices, diagnostics, and related opportunities in human medicine. Founded in 2000, the firm consists of an experienced team with a broad and complementary skill set that is particularly relevant to buildingsuccessful new biomedical companies. The Hatteras Venture Partners team brings operational experience, a successful track record, and a proven ability to enhance the value of the companies in which it invests. With three funds, the firm has more than $120 million under management.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Medical
  • Stage:Series A, Series B
  • Geography: United States, Canada

Investor stats

  • Total investments: 105
  • Round size: Series A $2.6M–$50M; Series B $4.5M–$90M
  • Lead/follow: 36% lead, 64% follow
  • Last fund: Likely still investing — fund raised in 2023

Portfolio highlights

  • Cardiosense — Cardiosense offers a physiological waveform AI platform to develop predictive biomarkers for the detection and treatment of disease. Its platform leverages multi-modal sensors and industry-leading AI to develop predictive biomarkers for the detection and treatment of disease.
  • Aer Therapeutics — Aer Therapeutics is a clinical stage biopharmaceutical company developing a novel inhaled approach to treat lung disease with excess mucus and mucus plugs.
  • Mercy BioAnalytics — We are making early stage cancer 100,000x easier to find using extracellular vesicles found in blood, specific to their parent cells.
Show all investments...

Medical Device Investor funding at a glance

Stats across 8.7k deals from 6.7k investors.

6.7k
investors
in Medical Device startups
8.7k
deals
in Medical Device startups
$4M
median round
in Medical Device startups
40%
lead investors
lead at least one round
20%
Seed
most common funding stage
90/10
VC / Angel
share of investor count

Access all 6731 investors in Medical Device startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Medical Device Investors investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 6731 investors investing in Medical Device startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists